D-0730-2026 Class II Ongoing

Recalled by MICRO LABS USA INC — Somerset, NJ

FDA drug recall D-0730-2026 was initiated by MICRO LABS USA INC on Jul 22, 2026 and is designated Class II. Reason for recall: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Aug 5, 2026
Initiation Date
Jul 22, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.

Reason for recall

Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.

Distribution pattern

Nationwide in the USA.

Code information

Lot # DLHU0031, Exp Date: 06/30/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0730-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0730-2026. Report a data issue: hello@regdatalab.com.